Different clinical characteristics of paroxysmal nocturnal hemoglobinuria in pediatric and adult patients

Haematologica. 2017 Mar;102(3):e76-e79. doi: 10.3324/haematol.2016.151852. Epub 2016 Nov 24.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Antilymphocyte Serum / therapeutic use
  • Cerebrovascular Disorders / etiology
  • Cerebrovascular Disorders / pathology
  • Cerebrovascular Disorders / prevention & control
  • Child
  • Child, Preschool
  • Cyclosporine / therapeutic use
  • Erythrocyte Transfusion*
  • Female
  • Hemoglobinuria, Paroxysmal / complications
  • Hemoglobinuria, Paroxysmal / drug therapy
  • Hemoglobinuria, Paroxysmal / pathology*
  • Hemolysis / drug effects
  • Heparin / therapeutic use
  • Humans
  • Infant
  • Infant, Newborn
  • L-Lactate Dehydrogenase / blood
  • Male
  • Middle Aged
  • Myocardial Infarction / etiology
  • Myocardial Infarction / pathology
  • Myocardial Infarction / prevention & control
  • Neutropenia / drug therapy
  • Neutropenia / pathology*
  • Neutrophils / drug effects
  • Neutrophils / pathology*
  • Registries*
  • Retrospective Studies
  • Thromboembolism / etiology
  • Thromboembolism / pathology
  • Thromboembolism / prevention & control
  • Warfarin / therapeutic use

Substances

  • Antilymphocyte Serum
  • Warfarin
  • Cyclosporine
  • Heparin
  • L-Lactate Dehydrogenase